Abstract | BACKGROUND AND OBJECTIVES: DESIGN AND METHODS: In study1, the Gln group (12 patients) received total parenteral nutrition (TPN) enriched with glutamine 20 g from day +1 after aPBSCT, while the placebo group (15 patients) received TPN lacking in glutamine (placebo). In study2, the Gln group (10 patients) received TPN enriched with glutamine 13.46 g from day +1, while the placebo group (11 patients) received a placebo. RESULTS: In the first study, a lymphocyte count >0.5 109/L was achieved on day 16.5 in the Gln group and on day 29 in the placebo group (p=0.005); in the second study, the lymphocyte count >0.5 109/L was achieved on day 18 in the Gln group and on day 29 in the placebo group (p=0.009). Lymphocyte subset analysis showed an increase of CD3+ and CD4+ and normalization of the CD16+CD56+ subset. Furthermore patients receiving GEPN showed a decrease in the mucositis severity peak calculated by the DMS (daily mucositis score: sum of the daily score of signs and symptoms) (p=0.047). INTERPRETATION AND CONCLUSIONS: GEPN is safe and effective and improves lymphocyte recovery after aPBSCT; further studies are needed to assess the clinical benefits of such an approach in order to justify its economic impact.
|
Authors | Nicola Piccirillo, Silvia De Matteis, Luca Laurenti, Patrizia Chiusolo, Federica Sorà, Mauro Pittiruti, Sergio Rutella, Silvia Cicconi, Alessia Fiorini, Giuseppe D'Onofrio, Giuseppe Leone, Simona Sica |
Journal | Haematologica
(Haematologica)
Vol. 88
Issue 2
Pg. 192-200
(Feb 2003)
ISSN: 0390-6078 [Print] Italy |
PMID | 12604409
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage)
- Female
- Glutamine
(administration & dosage, pharmacology)
- Hematologic Neoplasms
(therapy)
- Humans
- Immune System
(cytology, drug effects, growth & development)
- Lymphocyte Count
- Lymphocyte Subsets
(cytology)
- Male
- Middle Aged
- Mouth Mucosa
- Parenteral Nutrition
- Peripheral Blood Stem Cell Transplantation
(methods)
- Stomatitis
(prevention & control)
- Transplantation, Autologous
|